Mar 23, 2024, 15:01 | Societies

Giuseppe Viscardi: Our work led by Roberto Ferrara on waning effect of EGFR TKIs in adjuvant setting won best poster award

Giuseppe Viscardi, Lung Oncologist at Monaldi Hospital in Naples, shared on X/Twitter: “Great news from…

Mar 23, 2024, 14:54 | Societies

Rui Fu: Enjoying the opportunity to exchange ideas with fellow researchers at ELCC24

Rui Fu, Lung Cancer Researcher and Thoracic Cancer Surgeon at Guangdong Provincial People’s Hospital, on…

Mar 23, 2024, 13:08 | Blog

Herbert Loong: Always a pleasure to share session with my Partner In Crime at Princess Margaret Cancer Centre Canada, Alona Zer

Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post on…

Mar 21, 2024, 10:54 | Insight

The Swedish SCAN-B cohort, the HER2DX risk-score was found significantly associated with OS after adjustment for clinical variables and treatment regimen - ESMO Open

ESMO Open posted on X: "Hot off the press: among 757 patients with early HER2+ breast…

Mar 17, 2024, 19:51 | Insight

Tom Powles: New ESMO's guidlines for advanced bladder cancer Annals of Oncology - Enforumab Vedotin and pembrolizumab is the new standard of care

Tom Powles, Director of Barts Cancer Center, shared a post on X: "New ESMO's guidelines for…

Mar 16, 2024, 10:49 | Blog

Deniz Can Guven: We reviewed the available evidence regarding ICI use in patients with frailty

Deniz Can Guven, Medical Oncologist at Health Sciences University, Elazığ City Hospital, recently shared on…

Mar 16, 2024, 10:29 | Dialogues

OncoDaily Dialogues #6 – Navneet Singh / Hosted by Roupen Odabashian

In our ongoing series called "OncoDaily Dialogues," we consistently feature prominent individuals in the field…

Mar 12, 2024, 20:36 | Societies

Elisa Agostinetto: Happy to receive a ESMO Merit Travel Grant for the upcoming ESMO Breast24

Elisa Agostinetto, Research Fellow at Jules Bordet Institute in Brussels, shared a post on X/Twitter: "Happy to receive…

Mar 9, 2024, 20:06 | Societies

New ESMO Open podcast with Nicoletta Colombo, Florence Joly and Rita Canario - ESMO

The European Society for Medical Oncology (ESMO) shared a post on X: "New ESMO_Open podcast…

Mar 8, 2024, 19:21 | Societies

Our Editor Spotlight this week is Chiara Cremolini - ESMO Open

ESMO Open Journal announced on their X/Twitter page: "Our Editor Spotlight this week is Chiara…

Mar 8, 2024, 09:52 | Blog

Richard Simcock: Reflecting on a year of clinical cancer innovations

Richard Simcock, Chief Medical Officer at Macmillan Cancer Support, recently posted on LinkedIn: "It’s well…

Mar 3, 2024, 17:30 | Insight

Marlene Thomas: I want to applaud ESMO Targeted Anticancer Therapies for role modeling collaborative discussions among various healthcare stakeholders

Marlene Thomas, Head of CGP Portfolio Strategy at Roche, shared on LinkedIn: "I want to…

Mar 1, 2024, 15:46 | Blog

Edoardo Crimini: Such a honor to attend ESMO TAT 2024 with my fantastic mentors

Edoardo Crimini, Medical Oncology Resident and PhD candidate at University of Milan, made the following…

Feb 27, 2024, 15:37 | Blog

Deniz Can Guven: Join us for another great ESMOYOC YO4YO Virtual Session with Angela Lamarca

Deniz Can Guven, Committee Member at ESMO - European Society for Medical Oncology, recently shared…

Feb 26, 2024, 09:45 | Blog

David Blanchard: Nice family photo of the young generation ESMO preceptorship Lung Hong-Kong 2024!

David Blanchard, Thoracic Oncologist, Professor at the University Paris Saclay, Head of the Thoracic Group…

Feb 24, 2024, 10:59 | Societies

Bishal Gyawali: We had a very lively JSMO and ESMO joint symposium

Bishal Gyawali, Associate Professor and Medical Oncologist at Queen’s University, shared a post on X/Twitter: "We…

Feb 21, 2024, 18:13 | Insight

Erman Akkus: Tremelimumab plus durvalumab (STRIDE) in HCC-HIMALAYA update

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Tremelimumab plus durvalumab (STRIDE)…

Feb 19, 2024, 18:30 | Insight

Erman Akkus: Advanced breast cancer in 2023

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "Best of the year:…

Feb 19, 2024, 17:17 | Career

Stacie Lindsey: We are thrilled that the ESMO announced that the 2024 TAT Honorary Award is bestowed to Dr. Funda Meric-Bernstam

Stacie Lindsey, CEO of Cholangiocarcinoma Foundation, shared on LinkedIn: "We are thrilled that the ESMO…

Feb 18, 2024, 13:25 | Blog

Omar AbdiHamid: End of a 2-day preceptorship on the most lethal cancer in the region

Omar AbdiHamid, Clinical Oncology Specialist at HCGCCK Cancer Centre, recently posted on LinkedIn: "End of…

Feb 14, 2024, 13:26 | Blog

Françoise Meunier: High-Level Conference on Ending Financial Discrimination Against Cancer Survivors

Françoise Meunier recently shared on LinkedIn: "Why should cancer survivors be protected from financial discrimination?…

Feb 13, 2024, 07:45 | Blog

Christopher R. Flowers: Congratulations to Dr. Funda Meric-Bernstam on the ESMO Targeting Anticancer Therapy Honorary Award!

Christopher R. Flowers shared a post by ESMO on LinkedIn: "Congratulations to Dr. Funda Meric-Bernstam,…

Feb 11, 2024, 14:41 | Blog

Maria Babak: ESMO Advanced Course on Early Drug Development in Hong Kong was an incredible experience

Maria Babak, Assistant Professor at City University of Hong Kong, shared on LinkedIn: “Bridging the…

Feb 11, 2024, 12:19 | Blog

Benedikt Westphalen: I'm deeply grateful for the opportunity to chair the ESMO Translational Research and Precision Medicine Working

Benedikt Westphalen, Chair of Translational Research and Precision Medicine Working Group at ESMO, recently posted…

Feb 8, 2024, 17:44 | Societies

ESMO welcomes all the newly appointed Committee and Working Group Chairs

ESMO shared on their LinkedIn page: "ESMO is pleased to welcome all the newly appointed…

Jan 26, 2024, 08:01 | Blog

Rana Youness: I was honored to be invited as a guest speaker at the 16th Breast Gynecological and Immunooncology International Cancer Conference

Rana Youness, Assistant Professor at German International University, shared on LinkedIn: "I was honored to…

Jan 25, 2024, 15:53 | Blog

New peer-reviewed journal ESMO Gastrointestinal Oncology

Quoting ESMO - European Society for Medical Oncology on LinkedIn: "ESMO Daily Reporter: Over the…

Jan 23, 2024, 18:03 | Career

Christoph Zielinski: After eight very successful years as Editor in Chief of the online journal ESMOOpen, my mandate has run out with the end of 2023

Christoph Zielinski, Medical Director of Wiener Privatklinik and President of the Central European Cooperative Oncology…

Jan 2, 2024, 07:49 | Blog

Early breast cancer: Key patient management recommendations and algorithms - ESMO

ESMO – European Society for Medical Oncology shared on X/Twitter: "Early Breast Cancer: ESMO Guidelines…

Dec 30, 2023, 18:19 | Blog

Vivek Subbiah: Delighted to unwrap our small Precision Medicine present

Vivek Subbiah recently shared on LinkedIn: “Exciting Christmas Eve news! Just published in ESMO -…

Dec 24, 2023, 09:10 | Blog

Applications for the ESMO José Baselga Fellowship for Clinician Scientists are open - ESMO

ESMO – European Society for Medical Oncology shared on X: "Applications for the ESMO José…

Dec 21, 2023, 10:24 | Insight

Erman Akkus: 2023 updated MASCC and ESMO recommendations for prophylaxis of nausea and vomiting

Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "2023 updated MASCC and ESMO…

Dec 12, 2023, 12:40 | Societies

20 Posts Not To Miss From ESMO Asia Congress 2023

The ESMO Asia Congress 2023 took place in Singapore from 1 to 3 December. Our…

Dec 10, 2023, 16:53 | Positive

Matteo Lambertini: December 7, 2023 …a day to remember

Matteo Lambertini, Associate Professor at the University of Genova, shared on LinkedIn: "December 7, 2023…

Dec 4, 2023, 15:23 | Blog

Herbert Loong: Second super and fully booked ESMOYOC mentorship session ongoing at ESMOasia23

Herbert Loong, Clinical Associate Professor at The Chinese University of Hong Kong, shared a post…

Nov 26, 2023, 18:05 | Societies

Submit your abstract by 13 February for ESMO-Breast-24 - ESMO

ESMO posted on their LinkedIn page: "ESMOBreast24: Let your research findings stimulate discussions and help…

Nov 21, 2023, 13:57 | Blog

Vivek Subbiah: Honored to co-author with brilliant "Guru" of bladder cancer Guru Sonpavde.

Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared a…

Nov 19, 2023, 17:27 | Blog

Natalia Tissera: The first day of ESMO Advanced Course on Biomarkers for Precision Immuno-Oncology Across Tumours in Zurich, Switzerland

Natalia Tissera, Medical Oncologist at Vall d'Hebron Institute of Oncology (VHIO), shared on X/Twitter: “Starting…

Nov 19, 2023, 00:17 | Blog

Stephanie Graff: Another brilliant editor-in-chief announcement from The European Society for Medical Oncology, this time for ESMO Open

Stephanie Graff shared the following on Twitter: “Another brilliant editor-in-chief announcement from The European Society…

Nov 13, 2023, 12:55 | Societies

Over 3,400 slides, webcasts, abstracts and ePosters are now available on OncologyPRO - ESMO

ESMO shared on their X/Twitter: ''ESMO23: Over 3,400 slides, webcasts, abstracts and ePosters are now…

Nov 12, 2023, 17:50 | Insight

Andres Cervantes: Updated treatment recommendation for third-line treatment in advanced colorectal cancer from ESMO

Andres Cervantes, Professor Medical Oncologist at Hospital University of Valencia, posted on X/Twitter: "Updated treatment…

Nov 10, 2023, 23:38 | Blog

Rahul Gosain: ESMO23 Breast Cancer Highlights with Erika Hamilton

Rahul Gosain, Medical Director & Director of Regional Infusion Services, made the following post on…

Nov 4, 2023, 16:34 | Societies

Assen Dudov: The Bulgarian Cancer Scientific Society (BCSS) as the exclusive representative of the Bulgarian oncology community at the ESMO National Societies Committee!

Assen Dudov, President of Bulgarian Cancer Scientific Society, posted on LinkedIn. "Exciting News! I am…

Nov 2, 2023, 18:35 | Blog

Vivek S. Radhakrishnan: We have provided a comprehensive and contemporary review of immunotherapy in Hodgkin lymphoma

Vivek S. Radhakrishnan, Haematologic Oncologist at Cancer Care Group University Hospital of Southampton, recently shared…

Nov 2, 2023, 00:48 | Blog

Vivek Subbiah: Wow! What an amazing event on “Shaping the future of personalised healthcare for cancer patients”

Vivek Subbiah, posted the following on LinkedIn: "Wow! What an amazing event on 'Shaping the…

Nov 1, 2023, 03:26 | Insight

OncoDaily Highlights from ESMO with Karima Oualla։ Breast Cancer in Neoadjuvant Setting

[embed]https://www.youtube.com/watch?v=S0MaHb2uwAY[/embed] Karima Oualla, MD, MSc is a Professor of Medical Oncology at the Hassan II…

Oct 31, 2023, 04:25 | Dialogues

5min OncoDaily Updates with Chandler Park: Dr. Yüksel Urun on practice changing CheckMate 901 study for bladder cancer patients

[embed]https://www.youtube.com/watch?v=5qJ8T2SFHOA[/embed]

Oct 29, 2023, 17:50 | Blog

Humaid Al-Shamsi: We are delighted to announce the condensed version of the ESMO Conference in Dubai next month

Humaid Al-Shamsi, Director of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn: "We…

Oct 28, 2023, 15:53 | Positive

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 10

Our 2023 OncoDaily series on '100 Influential Women in Oncology: Key Opinion Leaders to Follow…

Oct 27, 2023, 03:39 | Insight

2023 edition recommendations for the Global Curriculum for Training in Medical Oncology - ESMO

Quoting the European Society for Medical Oncology (ESMO) on LinkedIn: "ESMO and the American Society…

Oct 26, 2023, 22:32 | Insight

Enrique Soto: The new ESMO and ASCO Global Curriculum in Medical Oncology is now online in Journal of European Society for Medical Oncology and JCO Global Oncology.

Enrique Soto, Medical Oncologist at the National Institute of Medical Science and Nutrition in Mexico…

Oct 26, 2023, 18:17 | Blog

Teresa Amaral: Did you know that so far the data presented at ESMO23 made it to publications in the NEJM

Teresa Amaral, recently tweeted: "Did you know that so far the data presented at ESMO23…

Oct 26, 2023, 17:00 | Blog

Antibody–drug conjugates improve outcomes for patients with inoperable or metastatic Breast Cancer - European Society for Medical Oncology

ESMO - European Society for Medical Oncology shared a post on LinkedIn: "Antibody–drug conjugates improve…

Oct 26, 2023, 09:21 | Blog

Françoise Meunier commends ESMO's call to EU member states to protect cancer survivors from financial discrimination

Françoise Meunier, Founder of the European Initiative on Ending Discrimination Against Cancer Survivors, shared a…

Oct 24, 2023, 15:50 | Blog

Caroline Markham: Thank you to both Dr. Lena Sharpe and Helena Ullgren for meeting with me at EONS16 to discuss the success of the PrEvCan campaign

Caroline Markham, Head of Strategic Partnerships at Touch Medical Media Services Ltd., recently posted on…

Oct 24, 2023, 15:36 | Blog

Lucjan Wyrwicz: Grab the most recent issue of the Lancet Oncology with the full report of the Keynote-859 study

Lucjan Wyrwicz, Professor at the National Institute of Oncology Maria Skłodowska-Curie - National Research Institute,…

Oct 24, 2023, 15:29 | Blog

Deniz Can Guven: We got the best poster award for palliative care

Deniz Can Guven, Medical Oncologist at Health Sciences University, recently shared on X/Twitter: "ESMO2023 excitement is…

Oct 24, 2023, 15:24 | Dialogues

5 min OncoDaily Updates with Chandler Park: Petros Grivas on the patient advocacy groups

[embed]https://www.youtube.com/watch?v=Ap9VbtYaz4o[/embed]

Oct 24, 2023, 13:48 | Blog

Toni Choueiri: Dr. Arlene Siefker-Radtkr presents the results of THOR

Quoting Toni Choueiri, the Director of the Lank Center for Genitourinary (GU) Oncology at Dana-Farber Cancer Institute, on…

Oct 24, 2023, 13:46 | Blog

Navneet Singh: Thank you very much Peters Solange and ESMO for enabling me to virtually attend this important meeting

Navneet Singh, Thoracic Oncologist and Professor at Postgraduate Institute of Medical Education and Research, Chandigarh,…

Oct 24, 2023, 13:45 | Blog

Stephen V Liu: ESMO23 - Dr. Solange Peters presents the PERLA randomized phase II study

Quoting Stephen V Liu, Associate Professor of Medicine and the Director of Thoracic Oncology at Georgetown University,…

Oct 23, 2023, 13:21 | Career

Florian Lordick: Honoured having received the FESMO award from ESMO President Andres Cervantes

Florian Lordick, Professor of Medicine and Director of the University Cancer Center Leipzig, shared on…

Oct 21, 2023, 19:09 | Societies

Evandro de Azambuja: We are over 34,000 members at ESMO

Evandro de Azambuja, ESMO Director of Membership 2023-2024, shared on his Twitter: "As the ESMO…

Oct 21, 2023, 13:59 | Societies

ESMO 2023 Social Media Ambassadors - European Society for Medical Oncology

Quoting the European Society for Medical Oncology on LinkedIn: "The Society is pleased to announce…

Oct 20, 2023, 20:19 | Blog

Nina Mojas: Events like ESMO23 provide important opportunities to come together and find potential solutions to the challenges faced by patients

Nina Mojas, Senior Vice President of Oncology at GSK, recently shared on LinkedIn: "As we…

Oct 18, 2023, 16:43 | Societies

All regular abstracts and posters can be found online - The European Society for Medical Oncology

The European Society for Medical Oncology recently shared on its X/Twitter page: "All regular abstracts…

Oct 18, 2023, 16:41 | Societies

ESMO-GROW, the first oncology-specific reporting guidance for RWE studies - The European Society for Medical Oncology

The European Society for Medical Oncology recently shared on its X/Twitter page: "ESMO announces the…

Oct 15, 2023, 17:35 | Societies

New webinar series by ESMO on precision medicine recommendations

The European Society for Medical Oncology (ESMO) shared on Twitter: Stay updated with the latest…

Oct 12, 2023, 19:25 | Blog

Arndt Vogel: I am very excited to be part of the new ESMO Journal 'ESMO Real World Data and Digital Oncology' as an associate editor.

Arndt Vogel, shared a post by Oncology Advance on X/Twitter, adding: "I am very excited…

Oct 6, 2023, 15:32 | Blog

Paolo Tarantino: Bright days ahead for ESMO journals!

Paolo Tarantino, Clinical Research Fellow at Dana-Farber Cancer Institute, shared on X/Twitter: “Congrats to the…

Oct 5, 2023, 17:41 | Blog

Vivek Subbiah: Mark your calendars if you are attending the ESMO MAP23 meeting in Paris, France this week, Oct 4-6.

Quoting Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, on…

Oct 4, 2023, 16:51 | Societies

The ESMO Research Fellowship programme provides young oncologists opportunities and support to develop high-quality research projects in either clinical or translational research. - European Society for Medical Oncology

Oct 1, 2023, 12:45 | Positive

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 6

In August, OncoDaily began its series on '100 Influential Women in Oncology: Key Opinion Leaders…

Oct 1, 2023, 00:34 | Positive

Vivek Subbiah: Can oncologists kick a football? Of course they kick cancer every day.

Oncologists are excited about an upcoming football event. "Finally 'Habemus football' after successful last SOCCER-ASCO#23…

Sep 28, 2023, 19:02 | Blog

Almost all late-breaking abstract titles and authors are now online. - ESMO

Quoting The European Society for Medical Oncology (ESMO) on X/Twitter: “That exciting time of the…

Sep 23, 2023, 19:57 | Blog

The first-ever ESMO Advanced Course on cholangiocarcinoma just took place in Barcelona. - The European Society for Medical Oncology (ESMO)

Quoting The European Society for Medical Oncology (ESMO) on X/Twitter: "The first-ever ESMO Advanced Course…

Sep 13, 2023, 13:50 | Blog

Erika Hamilton: ESMO Breast Cancer 2024 abstract submission system is NOW OPEN!

Erika Hamilton, Medical Oncologist, Director of Breast Cancer Research Program at Sarah Cannon Research Institute,…

Sep 7, 2023, 22:03 | Insight

Arndt Vogel: We provide comprehensive recommendations for PDAC.

Arndt Vogel, Managing senior consultant and professor in the Department of Gastroenterology, Hepatology and Endocrinology…

Sep 7, 2023, 19:32 | Blog

Matteo Lambertini: Dear young oncologists and friends, so much looking forward to seeing you in Madrid at ESMO23 for a successful ESMO - Eur. Oncology annual conference.

Quoting Matteo Lambertini, Associate Professor at Università di Genova, on X/Twitter: "Dear young oncologists and…

Sep 4, 2023, 18:00 | Blog

Marine Rushanyan: Grateful to European Society for Medical Oncology (ESMO) for the opportunity to attend the Advanced Course on Precision Oncology in Oncogen-Addicted NSCLC in Barcelona.

Sep 2, 2023, 19:28 | Positive

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2023: Part 2

Last week, on August 26, which is Women’s Equality Day in the United States, OncoDaily…

Aug 29, 2023, 18:56 | Insight

David Sebag-Montefiore: PROSPECT compared chemotherapy with chemoradiation. There was greater acute toxicity with pre-op chemotherapy.

David Sebag-Montefiore, the Clinical Director of Leeds Cancer Research Centre, shared on LinkedIn: "The title…

Aug 26, 2023, 02:44 | Societies

Will you be attending ESMO in Madrid? If so, please fill out the attendance interest survey for a 1-day ASCO-ECO workshop

The Fundación para la Excelencia y la Calidad de la Oncologia (ECO) partners with ASCO…

Aug 24, 2023, 18:16 | Blog

Paolo Tarantino: Retrospective study by Viale et al. on HER2-low breast cancer.

Quoting Paolo Tarantino, Research Fellow at the Dana-Farber Cancer Institute, on Twitter: ''Just out on…

Aug 22, 2023, 09:53 | Blog

David Planchard: Amphitheater full, impressive and top organization by the ESMO staff.

Quoting David Planchard, Thoracic Oncologist and Head of Thoracic Cancer Group at Gustave Roussy, stated…

Aug 17, 2023, 16:27 | Insight

Arndt Vogel: Excellent review, many open questions, Targeting cancers with KRAS-G12D mutations.

Arndt Vogel has recently shared 0n Twitter: ''Next batter up! Targeting cancers with KRAS-G12D mutations…

Aug 10, 2023, 18:37 | Career

Nominating committee of ESMO - Jarushka Naidoo

Kudos to Rebecca Dent as chair, and Dr.Toni Choueiri, Helena Linardou, Dr. Angela Lamarca, Dr. Christophe…

Aug 2, 2023, 18:31 | Blog

ESMO has reached a new remarkable milestone - ESMO

ESMO has reached a new remarkable milestone -- 30,000 members. Driven by a shared determination…

Jul 22, 2023, 18:24 | Blog

ESMO has announced the recipients of the 2023 ESMO Society Awards - ESMO

ESMO has announced the recipients of the 2023 ESMO Society Awards based on recognition of…

Jul 20, 2023, 05:57 | Opinion

ESMO proposes principles to improve Sponsoring and Monitoring of Clinical Trials and promote patient welfare - Jose Luis Perez-Garcia

1/ Bureaucracy is overwhelming Clinical Research! ESMO proposes principles to improve Sponsoring and Monitoring of…

Jul 19, 2023, 18:34 | Insight

In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still at the dawn - Paolo Tarantino

In breast oncology there is a pre-TDXd & a post-TDXd era, with the latter still…

Jul 17, 2023, 18:07 | Societies

ESMO Members are invited to vote for the candidates running for the ESMO Nomination Committee Chair and four Member positions - ESMO

ESMO Members are invited to vote for the candidates running for the ESMO Nomination Committee Chair…

Jul 14, 2023, 18:15 | Blog

Meta-analysis on the prognostic value of HER2-low in breast cancer - Guilherme Nader Marta

Now out in ESMO Open our meta-analysis led by chiara molinelli on the prognostic value of HER2-low…

Jul 9, 2023, 09:13 | Blog

Cancer patients' access to advanced genetic testing is not keeping up with the pace of discovery of targetable mutations and personalised therapies - European Society for Medical Oncology

Jul 6, 2023, 16:43 | Insight

We are opening a new travel grant that'll take you to #ESMO23 - ABC Global Alliance

We've got fantastic news! We are opening a new travel grant that'll take you to…

Jul 6, 2023, 09:08 | Positive

Congratulations Christoph Zielinski for this important achievement and for ESMO - European Society for Medical Oncology initiative! - Evandro de Azambuja

I remember when the idea of a new journal was first discussed... and not impact…

Jul 5, 2023, 05:17 | Blog

The formatted version of the ESMO Consensus Statements on HER2-low breast cancer is finally published - Paolo Tarantino

The formatted version of the ESMO Consensus Statements on HER2-low breast cancer is finally published…

May 25, 2023, 16:11 | Societies

At ESMO Breast we witnessed the true power of co-creation and cross-functional collaboration - Nana Scotto

Another great week closes for the whole of the Breast Cancer community following the ESMO…

May 16, 2023, 11:02 | Societies

ESMO POWG Practising Oncologists working group meeting in Berlin

#ESMO POWG #PractisingOncologists working group meeting in Berlin with intensive Friday’s afternoon brainstorming, how to minimize the gap…